Dr Jutta Reinhard-Rupp is a senior global health expert with more than 20 years of experience in the biopharmaceutical industry, specialized in the Global Health field focusing on malaria and neglected tropical diseases. Under her leadership, an integrated portfolio encompassing diagnostics and new treatment options combined with local capacity strengthening and trainings of healthcare workers has been developed. As Chair of the Board of the Pediatric Praziquantel Consortium, she steered the development of a new pediatric formulation for young children suffering from schistosomiasis which received EMA approval in 2023 and WHO pre-qualification in 2024.
She currently serves as an Ambassador for the H3D Foundation, strengthening and building partnerships for the Foundation. She also serves as scientific advisor at the DZIF (German Network for Infection Research), the CPCDI (Cross-Pharma Capacity Development Initiative) and the Global Health EDCTP3 Scientific Committee.
